Related Experiment Video
Updated: Jun 17, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Fibrogenic reactions in lung disease
Jun Araya1, Stephen L Nishimura
1Division of Respiratory Disease, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan. araya@jikei.ac.jp
Annual Review of Pathology
|January 19, 2010
Summary
Fibrotic lung diseases share common pathways despite varied causes. Targeting the transforming growth factor beta (TGF-beta) pathway offers a unified therapeutic approach for lung fibrosis.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Genetics
Background:
- Fibrotic lung reactions are a shared phenotype across diverse lung disorders.
- Individual variations in fibrosis extent suggest complex gene-environment interactions.
- Identifying common mechanisms is crucial for broad therapeutic impact.
Purpose of the Study:
- To identify a common molecular mechanism underlying various fibrotic lung diseases.
- To explore the potential of targeting shared pathways for novel therapeutic strategies.
Main Methods:
- Review of existing scientific literature on lung fibrotic responses.
- Analysis of cellular and cytokine networks involved in fibrosis.
- Focus on the role of the transforming growth factor beta (TGF-beta) pathway.
Main Results:
- Evidence converges on the central importance of the transforming growth factor beta (TGF-beta) pathway in all fibrogenic lung responses.
- The TGF-beta pathway acts as a common theme despite the complexity of fibrotic lung diseases.
Conclusions:
- The transforming growth factor beta (TGF-beta) pathway is a key common target for treating diverse fibrotic lung diseases.
- Therapies modulating TGF-beta activation hold potential for broad application in lung fibrosis treatment.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...